Category: Hong Kong Corporate News

Hong Kong Corporate News

South China Holdings Major Transaction: Disposal of Dongguan Land Use Right and Plant Building (2026 Circular)

Minichart

May 22, 2026

South China Holdings Announces Major Disposal of Land Use Ri...

Continue Reading 0

Hong Kong Corporate News

Chow Tai Fook Jewellery Group Announces Board Meeting to Approve 2026 Annual Results and Dividend Recommendation 1

Minichart

May 22, 2026

Potentially Price-Sensitive Information The confirmatio...

Continue Reading 0

Hong Kong Corporate News

HUTCHMED Announces Clinical Data Presentation at 2026 ASCO Annual Meeting for Savolitinib, Fruquintinib, and Surufatinib 1

Minichart

May 22, 2026

HUTCHMED to Present Key Clinical Data at 2026 ASCO Annual Me...

Continue Reading 0

Hong Kong Corporate News

GenScript Biotech Announces Legend Biotech’s Presentations at 2026 ASCO Annual Meeting, Highlighting CAR-T Therapy Advances 1

Minichart

May 22, 2026

GenScript Biotech: Legend Biotech to Present at 2026 ASCO An...

Continue Reading 0

Hong Kong Corporate News

Chalco Announces Major Investment and Equity Option in Guinea Alumina Project under Amended Mining Convention

Minichart

May 22, 2026

Chalco Announces Major Transaction: Investment and Construct...

Continue Reading 0

Hong Kong Corporate News

Ascentage Pharma Presents Promising Clinical Data on Olverembatinib, Lisaftoclax, and Alrizomadlin at ASCO 2026 Annual Meeting 1

Minichart

May 22, 2026

Ascentage Pharma Announces Promising Clinical Data at ASCO 2...

Continue Reading 0

Hong Kong Corporate News

Sino Biopharmaceutical’s M701 Bispecific Antibody Shows Promising Results in Phase III Trials for Malignant Ascites and Pleural Effusion at ASCO 2026 1

Minichart

May 22, 2026

Sino Biopharmaceutical Limited: Breakthrough Clinical Data f...

Continue Reading 0

Hong Kong Corporate News

Lenovo Group FY2025/26 Annual Results: Record Revenue, Strong AI Growth, and Strategic Outlook

Minichart

May 22, 2026

Lenovo Group Limited FY2025/26 Annual Results: Key Highlight...

Continue Reading 0

Hong Kong Corporate News

Sichuan Kelun-Biotech Announces Positive Phase 3 Results for Sacituzumab Tirumotecan and Lunbotinib at 2026 ASCO Meeting for Advanced Lung Cancer

Minichart

May 22, 2026

Sichuan Kelun-Biotech Announces Significant Clinical Results...

Continue Reading 0

Hong Kong Corporate News

Everest Medicines Substantial Shareholder CBC Group Increases Shareholding with HK$19.2 Million Purchase in May 2026 1

Minichart

May 22, 2026

Everest Medicines: Substantial Shareholder Increases Stake ...

Continue Reading 0